Sinride PM 1mg/500mg/15mg Tablet SR
Marketer
Indoscot Healthcare LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sinride PM 1mg/500mg/15mg Tablet SR
Metformin/Pioglitazone/Sitagliptin extended-release tablets (1mg/500mg/15mg) are a triple-combination therapy for managing blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia may occur when combined with other diabetes medications, alcohol, or missed meals. Regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart disease, or are pregnant/breastfeeding. Pre-treatment kidney function tests will be conducted. Limit alcohol consumption, as it can heighten the risk of side effects.
Uses of Sinride PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sinride PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Sinride PM 1mg/500mg/15mg Extended-Release tablet with food.
Common Side effects of Sinride PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sinride PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Sinride PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Consume this medication with a meal.
How Sinride PM 1mg/500mg/15mg Tablet SR works:
Sinride PM 1mg/500mg/15mg extended-release tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct modes of action—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sinride PM 1mg/500mg/15mg SR tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Sinride PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sinride PM 1mg/500mg/15mg tablet is likely not safe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Sinride PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sinride PM 1mg/500mg/15mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Sinride PM 1mg/500mg/15mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Sinride PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Sinride PM 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Sinride PM 1mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sinride PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently